| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/20/2010 | US7759104 Nutrient broth comprising measles virus; viral targeting of anticancer agents |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | US7758868 genes having a modification that results in replacement of a lysine residue to a leucine, histidine or arginine residue, causing the transferase enzymes to have increased fidelity compared to an enzyme encoded by a wild-type gene not having the modification; vaccines |
| 07/20/2010 | CA2197235C Adenovirus comprising a gene coding for glutathion peroxidase |
| 07/15/2010 | WO2010079081A1 Methods for recovering a virus or a viral antigen produced by cell culture |
| 07/15/2010 | US20100178684 Transgenic oncolytic viruses and uses thereof |
| 07/15/2010 | US20100178348 Myostatin Inhibition for Enhancing Muscle and/or Improving Muscle Function |
| 07/15/2010 | US20100178302 Chronic pathogen-expressing cell lines |
| 07/15/2010 | US20100178242 Labelling methods |
| 07/14/2010 | EP2206785A1 Improved expression of HIV polypeptides and production of virus-like particles |
| 07/14/2010 | EP1535927B1 Hbv precore protein capable of forming particles |
| 07/14/2010 | EP1337655B1 Lentiviral vectors for the treatment of neurodegenerative diseases |
| 07/14/2010 | EP1278824B1 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 07/14/2010 | EP1183332B1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
| 07/14/2010 | CN101775375A Preparation method of recombinant adeno-associated viruses containing EB virus latent membrane protein 1 and 2 genes and application thereof |
| 07/14/2010 | CN101775374A Production method of porcine epidemic diarrhea virus |
| 07/14/2010 | CN101775373A Method for activating frozen virus source of rice black-streaked dwarf virus |
| 07/14/2010 | CN101773667A Preparation method for vaccine of porcine circovirus II |
| 07/14/2010 | CN101117627B Pig epidemic diarrhea virus attenuated vaccine strain and uses thereof |
| 07/13/2010 | US7754464 Cellular permissivity factor for viruses and uses thereof |
| 07/13/2010 | US7754430 Papilloma virus capsomere vaccine formulations and methods of use |
| 07/13/2010 | US7754421 Detection of intact recombinant viruses |
| 07/13/2010 | US7754221 A recombinant Lister vaccinia virus, comprising a modified thymidine kinase gene, a modified hemagglutinin gene, and a modified F3gene or locus, each gene or locus is denactivated; the virus comprises heterologous nucleic acid encoding a gene; antitumor,carcinogenic, -proliferative agents; nontoxic |
| 07/13/2010 | CA2331440C Amphotropic retrovirus packaging cell line, process for its production and use thereof |
| 07/13/2010 | CA2309386C Variant loxp sequences and application of the same |
| 07/13/2010 | CA2297345C Novel antigenic class of avian reoviruses |
| 07/08/2010 | WO2010078331A1 Methods for selecting an hiv treatment regimen |
| 07/08/2010 | WO2010077986A2 Production of viral vaccine |
| 07/08/2010 | WO2010047955A3 N-linked glycosylation alteration in e0 and e2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 07/08/2010 | US20100173978 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor |
| 07/08/2010 | US20100173388 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 07/08/2010 | US20100173387 Method for producing adenovirus vectors for gene therapy and dna sequences used therefor |
| 07/08/2010 | US20100173298 Hcv gene |
| 07/08/2010 | US20100173280 Systems for Detection and Production of Respiratory, Herpes and Enteric Viruses |
| 07/08/2010 | US20100172936 Chimeric papillomavirus-like particles |
| 07/08/2010 | US20100172934 METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES |
| 07/08/2010 | US20100172928 Recombinant viral-based malaria vaccines |
| 07/08/2010 | US20100172908 Methods and compositions for treating diseases targeting maba1 |
| 07/08/2010 | US20100172877 Compositions and methods of use of an oncolytic vesicular stomatitis virus |
| 07/08/2010 | US20100172872 Treatment of Cancer Using HSV Mutant |
| 07/08/2010 | US20100172870 Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| 07/08/2010 | US20100172864 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| 07/08/2010 | CA2746228A1 Modified rsv f proteins and methods of their use |
| 07/07/2010 | EP2204452A1 Modified Vaccinia Ankara Virus variant |
| 07/07/2010 | EP2204180A2 Modified Vaccinia Virus Ankara for the vaccination of neonates |
| 07/07/2010 | EP2204179A2 Modified Vaccinia Virus Ankara for the vaccination of neonates |
| 07/07/2010 | EP1470218B1 Corona-virus-like particles comprising functionally deleted genomes |
| 07/07/2010 | EP1260581B1 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell |
| 07/07/2010 | EP1078094B1 Methods and compositions for producing viral particles |
| 07/07/2010 | EP0979284B2 Reagents for vaccination which generate a cd8 t cell immune response |
| 07/07/2010 | CN101768576A HSV1-TK (herpes simplex virus type 1-thymidine kinase) gene recombination oncolytic adenovirus, preparation method and application thereof |
| 07/07/2010 | CN101768575A Construction of recombinant rabies virus of double-expression G gene and biological property analysis thereof |
| 07/07/2010 | CN101768574A Recombinant herpes simplex virus for recombinant AAV5 / 5 virus vector packaging and application thereof |
| 07/07/2010 | CN101768206A Method for purifying recombinant human serum albumin protein and application thereof |
| 07/06/2010 | US7749973 Defective lentivirus pseudotyped with a lyssavirus envelope; selective transfer of genes into astrocytes of central nervous system; nervous system and brain disorders; viral diseases |
| 07/06/2010 | US7749745 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine |
| 07/06/2010 | US7749734 Attenuated chimeric flavivirus bearing attenuated Japanese encephalitis virus gene as backbone |
| 07/06/2010 | US7749493 Chimeric adenoviruses |
| 07/01/2010 | WO2010074575A2 Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv. |
| 07/01/2010 | WO2010074433A2 Novel bacteriophage and antibacterial composition comprising same |
| 07/01/2010 | WO2010074388A1 Novel bacteriophage and antibacterial compositions including the same |
| 07/01/2010 | WO2010074249A1 Nucleic acid derived from hepatitis c virus, and expression vector, transformed cell and hepatitis c virus particles each prepared by using same |
| 07/01/2010 | US20100167378 Preparation of virally inactivated biological fluids having high alpha-2-antiplasmin activity |
| 07/01/2010 | US20100167377 Recombinant viruses comprising the membrane-proximal domain of VSV G protein |
| 07/01/2010 | US20100167352 Infectious clones |
| 07/01/2010 | US20100167270 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 07/01/2010 | US20100166797 Gammaretrovirus associated with cancer |
| 07/01/2010 | US20100166787 Vaccines and methods for using the same |
| 07/01/2010 | US20100166709 Novel Bacteriophage and Antibacterial Composition Comprising the Same |
| 07/01/2010 | US20100166705 Culturing circular ssDNA viruses for the production of vaccines |
| 07/01/2010 | CA2748357A1 Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same |
| 06/30/2010 | EP2202315A1 Modified vaccinia ankara virus variant |
| 06/30/2010 | EP2202308A2 Methods and compositions for polypeptide engineering |
| 06/30/2010 | EP2202298A1 Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV |
| 06/30/2010 | EP2202297A1 Use of a chemotherapeutic agent in the preparation of a medicament for treating or ameliorating an adverse side effect associated with oncolytic viral therapy |
| 06/30/2010 | EP1721985B1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
| 06/30/2010 | EP1399183B1 Chimeric alphavirus replicon particles |
| 06/30/2010 | CN101760475A Recombinant retroviral vector |
| 06/30/2010 | CN101760467A Construction method of recombinant T4 bacteriophage for expressing Newcastle disease virus NP gene and application thereof |
| 06/29/2010 | US7745418 Compositions and methods for inhibiting viral replication |
| 06/29/2010 | US7745130 Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 06/29/2010 | US7744903 Epitopes confirmed to be recognized by T-cells derived from herpetic lesions or uterine cervix; vaccination; host cells |
| 06/29/2010 | US7744902 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 06/29/2010 | US7744901 A reassortant influenza virus comprises 6 internal genome segments from A/Ann Arbor/6/60 and one genome segment comprising a nucleic acid encoding a hemagglutinin polypeptide comprising the amino acid sequence of SEQ ID NO: 11; live, split or killed vaccine; immunostimulants |
| 06/29/2010 | US7744899 Preferentially kills tumor cells and not healthy cells; expresses only one gamma 134.5 gene copy and that comprises an expressibletumor-growth-inhibiting cytokine-encoding DNA; anticarcinogenic agents; antitumor agents; nervous system disorders; immunotherapy;tissue-targeted therapy |
| 06/29/2010 | US7744892 Optimized expression of HPV 52 L1 in yeast |
| 06/29/2010 | CA2225470C Method and apparatus for inactivating contaminants in blood products |
| 06/24/2010 | WO2010070098A1 High growth reassortant influenza a virus |
| 06/24/2010 | WO2010068968A1 Methods and compositions for use of a coccidiosis vaccine |
| 06/24/2010 | WO2010050833A3 A method of producing a pharmacologically stable form of lyophilised, active preparations of purified bacteriophages |
| 06/24/2010 | WO2009158618A4 Avian reoviridae |
| 06/24/2010 | US20100160420 Novel simian t-cell lymphotropic virus |
| 06/24/2010 | US20100160227 Signaling peptides |
| 06/24/2010 | US20100160221 Effect of tula on hiv |
| 06/24/2010 | US20100159467 Method for replicating the hepatitis c virus |
| 06/24/2010 | US20100158948 Adaptive mutations allow establishment of jfh1-based cell culture systems for hepatitis c virus genotype 4a |
| 06/24/2010 | US20100158947 Permissive cells and uses thereof |
| 06/24/2010 | US20100158944 Method for influenza virus protection |
| 06/24/2010 | US20100158942 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 06/24/2010 | US20100158941 Compositions and Methods for Treating Microbial Infections |